MANGOCEUTICALS INC - COM (MGRX)

CUSIP: 56270V106

Q3 2024 13F Holders as of 30 Sep 2024

Share change
+856,102
SEC-reported price per share
$0.24
Indexed holders
12
Value change
+$183,103
Number of buys
10
Number of sells
6

Security key

56270V106

Report period

Q3 2024

Indexed institutions

12

Top holders

10

Ownership snapshot

Top reported holders of MGRX - MANGOCEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Jonathan Arango
Disclosed value leader
Jonathan Arango
Comparable rows
0/8
Latest evidence
30 Jun 2024
3/4/5 13F Highest disclosed value: $1,000,000 8 rows are not safely comparable across share classes. Showing 1-6 of 8 holder rows.

Quick read

Jonathan Arango has the largest disclosed position value at $1M.

0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Jonathan Arango's linked filing trail.
Disclosed position value Top 5
Jonathan Arango $1M
Amanda Elizabeth Hammer $75K
CITADEL ADVISORS LLC $41.2K
MERCER GLOBAL ADVISORS INC /ADV $30.4K
Virtu Financial LLC $30K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 8 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Jonathan Arango
3/4/5
President, COO and Secretary, Director
—
denominator unverified
$1,000,000
1,000,000 shares
— 20 Mar 2023
Amanda Elizabeth Hammer
3/4/5
Chief Operating Officer
—
denominator unverified
$75,000
175,000 shares
— 03 Jun 2024
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$41,157
133,195 shares
— 30 Jun 2024
MERCER GLOBAL ADVISORS INC /ADV
13F
Company
13F
—
denominator unverified
$30,400
100,000 shares
— 30 Jun 2024
Virtu Financial LLC
13F
Company
13F
—
denominator unverified
$30,000
98,697 shares
— 30 Jun 2024
PEAK6 Investments LLC
13F
Company
13F
—
denominator unverified
$26,858
88,349 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
12
Shares
1,339,645
Indexed holders
12
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 indexed holders
6
Q3 2024 indexed holders
12
Indexed holder difference
6
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .